ALLO

Allogene Therapeutics Inc

May 18 • 03:16PM ET

1.92

-0.08 -3.75 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: FATE AUTL CRBU NKTX SANA

| Held by: VTI XBI IWM VXF IBB IWN FESM SCHA DFAS VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.77	Insider Own	27.58%	Shs Outstand	331.28M	Perf Week	-15.57%
Market Cap	664.42M	Forward P/E	-	EPS next Y	-0.80	Insider Trans	-0.30%	Shs Float	253.64M	Perf Month	-19.46%
Enterprise Value	478.58M	PEG	-	EPS next Q	-0.18	Inst Own	40.56%	Short Float	14.53%	Perf Quarter	-10.88%
Income	-173.76M	P/S	-	EPS this Y	17.63%	Inst Trans	-0.46%	Short Ratio	3.87	Perf Half Y	60.42%
Sales	0.00M	P/B	1.69	EPS next Y	-11.10%	ROA	-38.45%	Short Interest	36.86M	Perf YTD	40.51%
Book/sh	1.14	P/C	2.49	EPS next 5Y	6.46%	ROE	-52.32%	52W High	4.46 -56.84%	Perf Year	73.42%
Cash/sh	0.77	P/FCF	-	EPS past 3/5Y	28.61% 16.08%	ROIC	-49.43%	52W Low	0.98 95.59%	Perf 3Y	-68.34%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.85% 6.80%	Perf 5Y	-93.57%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	37.45%	Oper. Margin	-	ATR (14)	0.20	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.65	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	36.36	Recom	1.36
Dividend Gr. 3/5Y	- -	Current Ratio	9.65	EPS Q/Q	36.09%	SMA20	-13.42%	Beta	0.45	Target Price	8.35
Payout	-	Debt/Eq	0.29	Sales Q/Q	-	SMA50	-18.37%	Rel Volume	0.53	Prev Close	2.00
Employees	152	LT Debt/Eq	0.26	Earnings	May 13 AMC	SMA200	15.96%	Avg Volume	9.53M	Price	1.92
IPO	Oct 11, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.31% -100.00%	Trades		Volume	4,485,322	Change	-3.75%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)